2011
DOI: 10.1016/s0140-6736(10)62101-0
|View full text |Cite
|
Sign up to set email alerts
|

Non-small-cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
457
1
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 629 publications
(473 citation statements)
references
References 120 publications
2
457
1
1
Order By: Relevance
“…Almost 80% of lung cancers are non-small cell lung cancers (NSCLCs) [2] . Despite recent advancements in clinical and experimental oncology, the prognosis of patients with NSCLC remains poor, with a 5-year overall survival rate of approximately 11% [3] .…”
Section: Introductionmentioning
confidence: 99%
“…Almost 80% of lung cancers are non-small cell lung cancers (NSCLCs) [2] . Despite recent advancements in clinical and experimental oncology, the prognosis of patients with NSCLC remains poor, with a 5-year overall survival rate of approximately 11% [3] .…”
Section: Introductionmentioning
confidence: 99%
“…As the leading cause of cancer-related mortality globally, the annual burden of lung cancer is larger than that of any other cancers, for which more than 85% of those cases are currently classified as NSCLC (15)(16)(17). Despite recent advances in diagnosis and treatment, the predicted 5-year survival rate is only 15.9% which has only marginally improved during the past decades (18).…”
Section: Discussionmentioning
confidence: 99%
“…A minority of patients with lung cancer receives a treatment with curative intent, consisting of either radical surgery or definitive radiotherapy, administered either as single modality or combined with platinum-based chemotherapy [11,33,34].…”
Section: Introductionmentioning
confidence: 99%